uniQure (QURE) Accumulated Depreciation (2015 - 2025)
uniQure's (QURE) quarterly Accumulated Depreciation came in at $43.7 million in Q4 2025, up 38.16% year-on-year from $31.7 million in Q4 2024, and up 38.16% quarter-over-quarter from $31.7 million in Q4 2024.
uniQure (QURE) Accumulated Depreciation (2015 - 2025) Analysis & Trends
uniQure's Accumulated Depreciation history runs 11 years deep, the most recent figure standing at $43.7 million for Q4 2025.
- On a quarterly basis, Accumulated Depreciation rose 38.16% year-over-year to $43.7 million in Q4 2025; TTM through Dec 2025 was $43.7 million, a 38.16% increase from a year earlier, with the FY2025 full-year figure at $43.7 million, up 38.16% from the prior year.
- Accumulated Depreciation rose to $43.7 million in Q4 2025 per QURE's latest filing, from $31.7 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $55.7 million in Q4 2023 and bottomed at $31.7 million in Q4 2024.
- The 5-year median for Accumulated Depreciation is $43.7 million (2025), against an average of $42.4 million.
- Across the five-year window, Accumulated Depreciation slumped 43.14% in 2024 and surged 38.16% in 2025, its largest moves.
- Year by year, Accumulated Depreciation stood at $36.9 million in 2021, then climbed by 19.58% to $44.1 million in 2022, then increased by 26.17% to $55.7 million in 2023, then slumped by 43.14% to $31.7 million in 2024, then jumped by 38.16% to $43.7 million in 2025.
- Per Business Quant, the three latest QURE Accumulated Depreciation figures stand at $43.7 million (Q4 2025), $31.7 million (Q4 2024), and $55.7 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43.74 Mn |
| Dec 31, 2024 | 31.66 Mn |
| Dec 31, 2023 | 55.67 Mn |
| Dec 31, 2022 | 44.13 Mn |
| Dec 31, 2021 | 36.90 Mn |
| Dec 31, 2020 | 35.23 Mn |
| Dec 31, 2019 | 28.63 Mn |
| Dec 31, 2018 | 22.89 Mn |
| Sep 30, 2018 | 21.30 Mn |
| Jun 30, 2018 | 19.64 Mn |
| Mar 31, 2018 | 18.35 Mn |
| Dec 31, 2017 | 17.04 Mn |
| Sep 30, 2017 | 17.64 Mn |
| Jun 30, 2017 | 15.75 Mn |
| Mar 31, 2017 | 13.74 Mn |
| Dec 31, 2016 | 12.07 Mn |
| Dec 31, 2015 | 10.94 Mn |